Results 131 to 140 of about 13,035 (231)

Analytically Confirmed Opioid Detections From the Emerging Drugs Network of Australia

open access: yesEmergency Medicine Australasia, Volume 38, Issue 3, June 2026.
ABSTRACT Objective We describe analytically confirmed opioid‐related presentations to emergency departments (EDs) in Australia. Methods Presentations with analytically confirmed opioid exposure, between January 2021 and December 2024, were identified from the Emerging Drugs Network of Australia (EDNA) Clinical Registry.
J. Soderstrom   +53 more
wiley   +1 more source

Annual assessment of Echinococcus multilocularis surveillance reports submitted in 2026 in the context of Commission Delegated Regulation (EU) 2018/772

open access: yesEFSA Journal, Volume 24, Issue 6, June 2026.
Abstract This report comprises the 16th assessment of the Echinococcus multilocularis surveillance scientific reports, provided by Finland, Ireland, United Kingdom (Northern Ireland) and Norway on their respective surveillance programmes. Every year since 2012, EFSA presents the assessment to the European Commission (EC) in which the sampling strategy,
European Food Safety Authority (EFSA)   +2 more
wiley   +1 more source

Benzimidazole resistance in Haemonchus contortus in small ruminants: molecular mechanisms and diagnostic approaches. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist
Nowek Z   +8 more
europepmc   +1 more source

Novel 2-Aryl-1H-Benzimidazole Derivatives and Their Aza-Analogues as Promising Anti-Poxvirus Agents. [PDF]

open access: yesViruses
Manca V   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy